NDC 70518-4609-01 - Furosemide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70518-4609
- Requested NDC
- 70518-4609-01
- Package NDCs from labels
- 70518-4609-1, 70518-4609-0, 70518-4609-01
- Manufacturer
- REMEDYREPACK INC.
- Effective date
- 2026-04-23
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| FUROSEMIDE TABLETS USP, 20 mg, 40 mg, and 80 mg | REMEDYREPACK INC. | 2026-04-23 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70518-4609-0 | Furosemide | 50 in 1 BOX | TABLET | 50 | 1 | |
| 70518-4609-1 | Furosemide | 1 in 1 POUCH | TABLET | 1 | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| FUROSEMIDE | FUROSEMIDE | Aurobindo Pharma Limited | a504ee4b-3995-45f2-898c-91116dd81d19 | 2025-07-19 | Warnings, Adverse reactions | 313988 197732 310429 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | PD-Rx Pharmaceuticals, Inc. | 3ba730ab-90d4-478a-80b3-1ea3edb03e4d | 2025-07-15 | Warnings, Adverse reactions | ANDA076796 310429 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | NorthStar Rx LLC | fc3194a3-7e75-4551-8334-4a5cc22d9f8b | 2025-07-07 | Boxed warning, Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | Proficient Rx LP | 600ca175-be2b-4c43-b119-133ae21a5601 | 2025-07-01 | Warnings, Adverse reactions | 313988 7LXU5N7ZO5 |
| FUROSEMIDE | FUROSEMIDE | Baxter Healthcare Corporation | c71371a7-75c5-45b8-b762-8d782d4c71bc | 2025-06-30 | Boxed warning, Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | Sagent Pharmaceuticals | d76bd85a-8e57-477e-9607-c9435f1e26fb | 2025-06-26 | Boxed warning, Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Steritalc 2g | TALC | Novatech SA | c94e51d9-beef-4b06-e053-2a95a90a754a | 2025-06-25 | Warnings, Adverse reactions | 7SEV7J4R1U |
| Furosemide | FUROSEMIDE | Solco Healthcare LLC | 6a0fb397-63ae-4fce-bddf-16a91b1b7a2f | 2025-06-18 | Warnings, Adverse reactions | ANDA076796 43547-402 313988 197732 310429 f49380e9-82e1-439c-8cef-668d44a8e1ca 6a0fb397-63ae-4fce-bddf-16a91b1b7a2f 7LXU5N7ZO5 |
| SENSITIVE POCKET SUN | SENSITIVE POCKET SUN | Shantou Oushiya Biotechnology Co., Ltd | 36ac412f-e31f-6906-e063-6394a90a4a3d | 2025-06-14 | Warnings | 7SEV7J4R1U |
| Furosemide | FUROSEMIDE | Maiva Pharma Private Limited | e5880bf4-5037-4813-b7cc-656a6832ecb5 | 2025-06-13 | Warnings | 7LXU5N7ZO5 |
| UDSxMP Medicated System | FUROSEMIDE, BENZALKONIUM CHLORIDE | Wellbeing Medical Supply | 06b901dc-0f1d-424f-8c4b-a29113cbab25 | 2025-06-12 | Warnings, Adverse reactions | 310429 |
| UDSx Medicated System | FUROSEMIDE, BENZALKONIUM CHLORIDE | Wellbeing Medical Supply | 8f1df75b-101a-45da-924a-2767c34a4efe | 2025-06-12 | Warnings, Adverse reactions | 310429 |
| Furosemide | FUROSEMIDE | Prefferred Pharmaceuticals Inc. | ede9846b-b4c5-4be2-9188-fd65e66cd893 | 2025-04-30 | Warnings, Adverse reactions | 310429 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | Coupler LLC | 33ec71e2-8fbd-0703-e063-6294a90a62e1 | 2025-04-29 | Warnings, Adverse reactions | 197732 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | Chartwell RX, LLC | 8ebd2f10-acfc-48a4-a5db-f20377bda9ce | 2025-03-26 | Warnings, Adverse reactions | 313988 310429 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | Hikma Pharmaceuticals USA Inc. | ddfc41a9-37d4-49c1-bbf3-969a98cd649c | 2025-03-10 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | Avenacy Inc. | 7d0db0f7-bf4f-4b0b-9359-2a838626e04b | 2025-02-28 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | Rising Pharma Holdings, Inc. | 6101b9b4-f3ef-438e-a857-b4ea55ffc679 | 2025-02-21 | Warnings, Adverse reactions | 313988 197732 310429 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | Camber Pharmaceuticals, Inc. | f6221cce-e586-4002-bd14-6ec22eb14e2e | 2025-01-30 | Boxed warning, Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | Ipca Laboratories Limited | 0acd293b-ecab-4879-a8e7-cd1b76148f2a | 2025-01-20 | Warnings, Adverse reactions | 313988 197732 310429 7LXU5N7ZO5 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.